Literature DB >> 27430083

Head and Neck Cutaneous Squamous Cell Carcinoma Clinicopathological Risk Factors according to Age and Gender: A Population-based Study.

Itay Wiser, Alon Scope, David Azriel, Elhanan Zloczower, Narin N Carmel, Avshalom Shalom.   

Abstract

BACKGROUND: Clinicopathological risk factors for cutaneous squamous cell carcinoma of the head and neck (CSCCHN) are associated with local recurrence and metastasis.
OBJECTIVES: To compare the incidence and risk factors of CSCCHN by age and gender in order to help refine the clinical evaluation and treatment process.
METHODS: Clinical and pathological data of all patients diagnosed with CSCCHN during 2009-2011 were obtained from a central pathology laboratory in Israel. Estimated incidence rate calculation was standardized to the 2010 Israeli population. Independent risk factors for poorly differentiated CSCCHN were analyzed using logistic regression.
RESULTS: CSCCHN was diagnosed in 621 patients. Mean age was 75.2 years; mean tumor horizontal diameter was 11.1 ± 6.8 mm. The overall estimated incidence rate in males was higher than in females (106.2 vs. 54.3 per 1,000,000, P 0.001). Twenty cases (3.2%) had poorly differentiated CSCCHN. Scalp and ear anatomic locations were observed more often in males than in females (22.1% vs. 6.1% and 20.3% vs. 3.3%, respectively, P < 0.001). Per 1 mm increment, tumor horizontal diameter increased the risk for poorly differentiated CSCCHN by 6.7% (95% CI 1.3-12.4%, P = 0.014).
CONCLUSIONS: CSCCHN clinicopathological risk factors are not distributed evenly among different age and gender groups.

Entities:  

Mesh:

Year:  2016        PMID: 27430083

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  2 in total

1.  Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.

Authors:  Eunmiri Roh; Yaping Han; Kanamata Reddy; Tatyana A Zykova; Mee Hyun Lee; Ke Yao; Ruihua Bai; Clara Curiel-Lewandrowski; Zigang Dong
Journal:  Oncogene       Date:  2020-04-10       Impact factor: 9.867

2.  Unresectable cutaneous squamous cell carcinoma of the forehead with MLH1 mutation showing dramatic response to Programmed Cell Death Protein 1 Inhibitor Therapy.

Authors:  Jed H Assam; Steven Powell; William C Spanos
Journal:  Clin Skin Cancer       Date:  2016-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.